share_log

Merck & Co | CERT: Others

Merck & Co | CERT: Others

默沙东 | CERT:其他
美股SEC公告 ·  05/30 16:43

Moomoo AI 已提取核心信息

The New York Stock Exchange has approved the listing and registration of a series of notes guaranteed by Merck & Co., Inc. These securities are issued by MSD Netherlands Capital B.V. and include 3.250% Notes due in 2032, 3.500% Notes due in 2037, 3.700% Notes due in 2044, and 3.750% Notes due in 2054. The approval by the NYSE is a significant step for Merck & Co., as it allows the company to expand its financial instruments in the market. The listing under the Exchange Act of 1934 was confirmed on May 30, 2024.
The New York Stock Exchange has approved the listing and registration of a series of notes guaranteed by Merck & Co., Inc. These securities are issued by MSD Netherlands Capital B.V. and include 3.250% Notes due in 2032, 3.500% Notes due in 2037, 3.700% Notes due in 2044, and 3.750% Notes due in 2054. The approval by the NYSE is a significant step for Merck & Co., as it allows the company to expand its financial instruments in the market. The listing under the Exchange Act of 1934 was confirmed on May 30, 2024.
纽约证券交易所已批准由默沙东公司担保的一系列票据的上市和注册。这些证券由默沙东荷兰资本有限公司发行,包括2032年到期的3.250%的票据、2037年到期的3.500%的票据、2044年到期的3.700%的票据以及2054年到期的3.750%的票据。纽约证券交易所的批准是默沙东公司迈出的重要一步,因为它使公司能够在市场上扩展其金融工具。根据1934年《交易法》进行的上市于2024年5月30日得到确认。
纽约证券交易所已批准由默沙东公司担保的一系列票据的上市和注册。这些证券由默沙东荷兰资本有限公司发行,包括2032年到期的3.250%的票据、2037年到期的3.500%的票据、2044年到期的3.700%的票据以及2054年到期的3.750%的票据。纽约证券交易所的批准是默沙东公司迈出的重要一步,因为它使公司能够在市场上扩展其金融工具。根据1934年《交易法》进行的上市于2024年5月30日得到确认。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息